Does EVOLOCUMAB Cause Nasal congestion? 625 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 625 reports of Nasal congestion have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.4% of all adverse event reports for EVOLOCUMAB.
625
Reports of Nasal congestion with EVOLOCUMAB
0.4%
of all EVOLOCUMAB reports
1
Deaths
19
Hospitalizations
How Dangerous Is Nasal congestion From EVOLOCUMAB?
Of the 625 reports, 1 (0.2%) resulted in death, 19 (3.0%) required hospitalization, and 3 (0.5%) were considered life-threatening.
Is Nasal congestion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 625 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Nasal congestion?
DUPILUMAB (3,250)
AMBRISENTAN (3,019)
TREPROSTINIL (2,053)
OMALIZUMAB (1,883)
ADALIMUMAB (1,615)
MACITENTAN (1,497)
ALBUTEROL (1,434)
ETANERCEPT (1,379)
NIRMATRELVIR\RITONAVIR (1,339)
TOFACITINIB (1,325)
Which EVOLOCUMAB Alternatives Have Lower Nasal congestion Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE